5.41
-0.035(-0.64%)
Currency In USD
| Previous Close | 5.44 |
| Open | 5.38 |
| Day High | 5.57 |
| Day Low | 5.4 |
| 52-Week High | 9.33 |
| 52-Week Low | 4.32 |
| Volume | 1M |
| Average Volume | 4.29M |
| Market Cap | 1.29B |
| PE | -31.79 |
| EPS | -0.17 |
| Moving Average 50 Days | 5.39 |
| Moving Average 200 Days | 5.75 |
| Change | -0.04 |
If you invested $1000 in Ardelyx, Inc. (ARDX) 10 years ago, it would be worth $1,393.04 as of March 13, 2025 at a share price of $5.405. Whereas If you bought $1000 worth of Ardelyx, Inc. (ARDX) shares 5 years ago, it would be worth $4,094.7 as of March 13, 2025 at a share price of $5.405.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
GlobeNewswire Inc.
5 hours ago
Award established to recognize leaders in the field of chronic kidney disease advocacyWALTHAM, Mass., March 13, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and comme
Tenapanor Approved in China for Hyperphosphatemia
GlobeNewswire Inc.
Feb 26, 2025 12:00 PM GMT
Ardelyx to receive $5 million milestone payment from Fosun Pharma following approvalWALTHAM, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commerci
Ardelyx to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Feb 25, 2025 9:15 PM GMT
WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs